Filana Therapeutics (FLNA) Operating Margin (2010 - 2013)
Filana Therapeutics (FLNA) posted quarterly Operating Margin of 93.36% for Q4 2013, up 16791.0% year-over-year from N/an in Q4 2012, and up 335.56% quarter-over-quarter from 39.63% in Q3 2013.
Filana Therapeutics (FLNA) Operating Margin (2010 - 2013) Analysis & Trends
Filana Therapeutics' Operating Margin history runs 4 years deep, the most recent figure standing at 93.36% for Q4 2013.
- In Q4 2013, Operating Margin rose 16791.0% year-over-year to 93.36%; the TTM figure through Dec 2013 stood at 76.28% (up 11205.0% YoY), while the FY2013 annual figure was 76.28%, up 11206.0% from the prior year.
- Operating Margin for Q4 2013 stood at 93.36%, up from 39.63% in the prior quarter.
- The five-year high for Operating Margin was 93.36% in Q4 2013, with the low at 118.75% in Q4 2010.
- The 4-year median for Operating Margin is 37.21% (2011), against an average of 32.01%.
- The sharpest annual moves came in 2012 and 2013: Operating Margin slumped 5329 bps in 2012, then soared 16791 bps in 2013.
- Filana Therapeutics' Operating Margin stood at 118.75% in 2010, then soared by 82 bps to 21.26% in 2011, then slumped by 251 bps to 74.55% in 2012, then soared by 225 bps to 93.36% in 2013.
- Business Quant data shows FLNA's Operating Margin at 93.36% in Q4 2013, 39.63% in Q3 2013, and 16.28% in Q2 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 17.93% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -35.57% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.36% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.75% |
| 10 | Filana Therapeutics | 46.00 Mn | 46.00 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 93.36% |
| Sep 30, 2013 | -39.63% |
| Jun 30, 2013 | -16.28% |
| Mar 31, 2013 | -22.63% |
| Dec 31, 2012 | -74.55% |
| Sep 30, 2012 | -60.73% |
| Jun 30, 2012 | -9.29% |
| Mar 31, 2012 | -4.98% |
| Dec 31, 2011 | -21.26% |
| Sep 30, 2011 | -37.21% |
| Jun 30, 2011 | -51.89% |
| Mar 31, 2011 | -14.80% |
| Dec 31, 2010 | -118.75% |
| Sep 30, 2010 | -54.30% |
| Jun 30, 2010 | -47.25% |